Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voltz, R.
Right arrow Articles by Hohlfeld, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voltz, R.
Right arrow Articles by Hohlfeld, R.
NEUROLOGY 1996;46:250-251
© 1996 American Academy of Neurology

Reversible encephalopathy with cerebral vasospasm in a Guillain-Barre syndrome patient treated with intravenous immunoglobulin

R. Voltz, MD, F. V. Rosen, MD, T. Yousry, MD, J. Beck and R. Hohlfeld, MD

From the Department of Neurology (Drs. Voltz, V. Rosen, and Hohlfeld), the Department for Diagnostic Radiology (Dr. Yousry), the Department of Neurosurgery (J. Beck), Klinikum Grobhadern, Munchen, and the Department of Neuroimmunology (Drs. Voltz and Hohlfeld), Max-Planck-Institute, Martinsried, Germany.
Received March 14, 1995. Accepted in final form May 20, 1995.
Address correspondence and reprint requests to Dr. Raymond Voltz, Department of Neurology, Klinikum Grobhadern, 81366 Munchen, Germany.

Article abstract-We report a patient with a reversible multifocal encephalopathy that developed 3 days after completion of treatment with intravenous immunoglobulin for Guillain-Barre syndrome. Magnetic resonance imaging showed reversible bioccipital white matter changes, and transcranial Doppler demonstrated transiently increased flow rates in all major cerebral arteries. We conclude that intravenous immunoglobulin therapy caused cerebral arterial vasospasm and a reversible encephalopathy.

NEUROLOGY 1996;46: 250-251




This article has been cited by other articles:


Home page
 J Child NeurolHome page
H. R. Kayyali, A. T. Abdelmoity, M. C. Morriss, and W. D. Graf
Cerebral Venous Thrombosis After Immune Thrombocytopenic Purpura and Anti-D Immune Globulin Therapy
J Child Neurol, March 1, 2008; 23(3): 325 - 330.
[Abstract] [PDF]

Home page
 Nephrol Dial TransplantHome page
S. Belmouaz, E. Desport, F. Leroy, J. Teynie, J. Hannequin, R. A. Ayache, F. Bridoux, and G. Touchard
Posterior reversible encephalopathy induced by intravenous immunoglobulin
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 417 - 419.
[Full Text] [PDF]

Home page
 BloodHome page
S. Jarius, P. Eichhorn, M. H. Albert, S. Wagenpfeil, M. Wick, B. H. Belohradsky, R. Hohlfeld, D. E. Jenne, and R. Voltz
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNF{alpha}-dependent and Fc-receptor-independent way
Blood, May 15, 2007; 109(10): 4376 - 4382.
[Abstract] [Full Text] [PDF]

Home page
 ANN INTERN MEDHome page
L. H. Calabrese, D. W. Dodick, T. J. Schwedt, and A. B. Singhal
Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
Ann Intern Med, January 2, 2007; 146(1): 34 - 44.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Neuroradiol.Home page
A. Wada, R. Yoshida, K. Oda, E. Fukuba, N. Uchida, and H. Kitagaki
Acute Encephalopathy Associated with Intravenous Immunoglobulin Therapy
AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2311 - 2315.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
U Katz and Y Shoenfeld
Review: intravenous immunoglobulin therapy and thromboembolic complications
Lupus, October 1, 2005; 14(10): 802 - 808.
[Abstract] [PDF]

Home page
 NeurologyHome page
J. B. Caress, M. S. Cartwright, P. D. Donofrio, and J. E. Peacock Jr.
The clinical features of 16 cases of stroke associated with administration of IVIg
Neurology, June 10, 2003; 60(11): 1822 - 1824.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. C. Dalakas
Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies
Neurology, December 24, 2002; 59(90126): S13 - 21.
[Abstract] [Full Text]

Home page
 NeurologyHome page
T. H. Brannagan III
Intravenous gammaglobulin (IVIg) for treatment of CIDP and related immune-mediated neuropathies
Neurology, December 24, 2002; 59(90126): S33 - 40.
[Abstract] [Full Text]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
C M Wiles, P Brown, H Chapel, R Guerrini, R A C Hughes, T D Martin, P McCrone, J Newsom-Davis, J Palace, J H Rees, et al.
Intravenous immunoglobulin in neurological disease: a specialist review
J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 440 - 448.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Okumura, H Ushida, K Maruyama, K Itomi, Y Ishiguro, M Takahashi, A Osuga, T Negoro, and K Watanabe
Guillain-Barre syndrome associated with central nervous system lesions
Arch. Dis. Child., April 1, 2002; 86(4): 304 - 306.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
M. LEWIS, P. MADDISON, B. TURNER, and A. J WILLS
Intravenous immunoglobulin causing reversible posterior leukoencephalopathy syndrome?
J. Neurol. Neurosurg. Psychiatry, November 1, 2000; 69(5): 704 - 704.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by AAN Enterprises, Inc.